NEUCHATEL, Switzerland--(BUSINESS WIRE)--The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both ...
FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...
Please provide your email address to receive an email when new articles are posted on . VIENNA — A clearer definition of what extended depth of focus lenses are or should be is needed because ...
Major ophthalmic events in the first quarter of 2026 included treatments for presbyopia, age-related macular degeneration ...
Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, George O. Waring IV, MD, FACS, reports ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof® IQ Vivity® and Clareon® Vivity ...
IRVINE, Calif., Sept. 28, 2022 /PRNewswire/ -- Johnson & Johnson Vision,** a global leader in eye health and part of Johnson & Johnson MedTech,*** today announced availability of our ...
JACKSONVILLE, Fla., March 12, 2026--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced U.S. Food and Drug Administration (FDA) approval of TECNIS PureSee IOL, an extended depth of focus (EDOF) ...
Add Yahoo as a preferred source to see more of our stories on Google. The approval adds to J&J’s surgical vision portfolio Johnson & Johnson (J&J) has received approval from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results